Search Within

Taha Merghoub

  1. "Epidemiology and Biostatistics"
Formats
  1. Journal Article (33)
  2. Meeting Abstract (19)
Groups
  1. Department of Medicine (52)
  2. Epidemiology and Biostatistics (52)
  3. Melanoma and Immunotherapeutics Service (52)
  4. Solid Tumor Oncology Division (52)
  5. GSK Faculty (44)
  6. Biostatistics Service (41)

More Groups

People
  1. Jedd Wolchok (34)
  2. Katherine Panageas (18)
  3. Sadna Budhu (14)
  4. Cailian Liu (12)
  5. Matthew Hellmann (12)
  6. Vinod Balachandran (11)

More People

Years
  1. 2024 (1)
  2. 2023 (2)
  3. 2022 (12)
  4. 2021 (6)
  5. 2020 (8)
  6. 2019 (5)

More Years

Publications
  1. Journal of Clinical Oncology (10)
  2. Journal for ImmunoTherapy of Cancer (6)
  3. Cancer Research (5)
  4. Cancer Cell (4)
  5. Nature (4)
  6. Blood (2)

More Publications

Publishers
  1. American Society of Clinical Oncology (11)
  2. American Association for Cancer Research (9)
  3. Biomed Central Ltd (6)
  4. Cell Press (6)
  5. Nature Publishing Group (5)
  6. American Association for the Advancement of Science (3)

More Publishers

Results (52)

Export to EndNote / Excel | PubMed

Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Clinical and molecular features of acquired resistance to immunotherapy in non-small cell lung cancer
    Journal Article

    Memon, D.; Schoenfeld, A. J.; Ye, D.; Fromm, G.; Rizvi, H.; Zhang, X.; Keddar, M. R.; Mathew, D.; Yoo, K. J.; Qiu, J.; more...
    Cancer Cell (2024)

    Fulltext@MSK | Save
  • Determinants of survival with combined HER2 and PD-1 blockade in metastatic esophagogastric cancer
    Journal Article

    Maron, S. B.; Chatila, W.; Walch, H.; Chou, J. F.; Ceglia, N.; Ptashkin, R.; Do, R. K. G.; Paroder, V.; Pandit-Taskar, N.; Lewis, J. S.; more...
    Clinical Cancer Research (2023)

    Fulltext@MSK | Save
  • The ectonucleotidase CD39 identifies tumor-reactive CD8(+) T cells predictive of immune checkpoint blockade efficacy in human lung cancer
    Journal Article

    Chow, A.; Uddin, F. Z.; Liu, M.; Dobrin, A.; Nabet, B. Y.; Mangarin, L.; Lavin, Y.; Rizvi, H.; Tischfield, S. E.; Quintanal-Villalonga, A.; more...
    Immunity (2023)

    Fulltext@MSK | Save
  • Lag3 blockade in combination with GITR improves anti-tumor immune responses in a preclinical melanoma model
    Meeting Abstract

    Maniyar, R.; Zappasodi, R.; Elhanati, Y.; St Jean, S.; Carrasco, S.; Greenbaum, B.; Wolchok, J.; Merghoub, T.
    Journal for ImmunoTherapy of Cancer (2022)

    Fulltext@MSK | Save
  • Defining the balance of anti-viral and anti-tumor T cell responses to oncolytic virus therapy using single cell approaches
    Meeting Abstract

    Burman, B.; Ceglia, N.; Hirschhorn, D.; Budhu, S.; Mangarin, L.; Oseledchyk, A.; Bykov, Y.; McPherson, A.; Shah, S.; Wolchok, J.; more...
    Cancer Research (2022)

    Fulltext@MSK | Save
  • Biomarkers of response to neoadjuvant atezolizumab with gemcitabine and cisplatin in muscle-invasive bladder cancer
    Meeting Abstract

    Lattanzi, M.; Solovyov, A.; Lihm, J.; Quinlan, C.; Whiting, K.; Li, H.; Al-Ahmadie, H. A.; Teo, M. Y.; Aggen, D. H.; Ostrovnaya, I.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Phase I trial of adjuvant autogene cevumeran, an individualized mRNA neoantigen vaccine, for pancreatic ductal adenocarcinoma
    Meeting Abstract

    Balachandran, V. P.; Rojas, L. A.; Sethna, Z.; Soares, K.; Derhovanessian, E.; Mueller, F.; Yadav, M.; Basturk, O.; Gonen, M.; Wei, A. C. C.; more...
    Journal of Clinical Oncology (2022)

    Fulltext@MSK | Save
  • Increased p53 expression induced by APR-246 reprograms tumor-associated macrophages to augment immune checkpoint blockade
    Journal Article

    Ghosh, A.; Michels, J.; Mezzadra, R.; Venkatesh, D.; Dong, L.; Gomez, R.; Samaan, F.; Ho, Y. J.; Campesato, L. F.; Mangarin, L.; more...
    Journal of Clinical Investigation (2022)

    Fulltext@MSK | Save
  • Neoantigen quality predicts immunoediting in survivors of pancreatic cancer
    Journal Article

    Łuksza, M.; Sethna, Z. M.; Rojas, L. A.; Lihm, J.; Bravi, B.; Elhanati, Y.; Soares, K.; Amisaki, M.; Dobrin, A.; Hoyos, D.; more...
    Nature (2022)

    Fulltext@MSK | Save
  • Fundamental immune–oncogenicity trade-offs define driver mutation fitness
    Journal Article

    Hoyos, D.; Zappasodi, R.; Schulze, I.; Sethna, Z.; de Andrade, K. C.; Bajorin, D. F.; Bandlamudi, C.; Callahan, M. K.; Funt, S. A.; Hadrup, S. R.; more...
    Nature (2022)

    Fulltext@MSK | Save